NMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance
|
|
- Bruce Pitts
- 5 years ago
- Views:
Transcription
1 Vol. 19 No. 1(Suppl.) January 2000 Journal of Pain and Symptom Management S7 Proceedings Supplement NDMA-Receptor Antagonists: Evolving Role in Analgesia NMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance Donald D. Price, PhD, David J. Mayer, PhD, Jianren Mao, PhD, and Frank S. Caruso, PhD Departments of Oral and Maxillofacial Surgery and Neuroscience, University of Florida, (D.D.P), Florida; Department of Anesthesiology, Medical College of Virginia, (D.J.M., J.M.), Virginia; and Algos Pharmaceutical Corporation (F.S.C.), Neptune, New Jersey, USA Abstract A model proposing that N-methyl-D-aspartate (NMDA) receptor and opioid receptor mechanisms overlap and interact within the same dorsal horn nociceptive neurons makes several predictions. First, hyperalgesia should be associated with opioid tolerance. Second, both hyperalgesia and tolerance to opioid-analgesia should be blocked by an NMDA-receptor antagonist. Results from our laboratory and others support these predictions and point to several clinical implications. One is that, in addition to preventing tolerance and dependence, combining NMDA-receptor antagonists with both opioid and nonopioid analgesics may increase their analgesic potency. Preclinical animal studies demonstrate these advantages and underscore the practicality of the combined administration of nontoxic NMDA-receptor antagonists with various types of analgesic drugs. J Pain Symptom Manage 2000;S7 S11. U.S. Cancer Pain Relief Committee, Key Words NMDA-Receptor antagonists, hyperalgesia, opioid tolerance, dextromethorphan Introduction An emerging principle in new pharmacological strategies for treating pain is to combine existing analgesic agents with nontoxic N-methyld-aspartate (NMDA) receptor antagonists to Address reprint requests to: Donald D. Price, PhD, Claude Denson Pepper Center for Research on Oral Health in Aging, Health Science Center, PO Box , Gainesville, FL , USA. Accepted for publication: September 17, enhance their analgesic effects, extend their duration, and prevent tolerance to their repeated administration. Our contribution to this principle has been the discovery of neurochemical mechanisms by which NMDA-receptor antagonists exert these effects, followed by preclinical tests of combinations of dextromethorphan (DM) with opioid and nonopioid analgesic agents. Here we briefly review the mechanisms by which NMDA-receptor antagonists enhance analgesic effects of these agents, and we note the preclinical studies that have led to human clinical trials. U.S. Cancer Pain Relief Committee, /00/$ see front matter Published by Elsevier, New York, New York PII S (99)
2 S8 Price et al. Vol. 19 No. 1(Suppl.) January 2000 Overview of NMDA-Receptor Mechanisms of Pain The mechanisms by which nontoxic NMDAreceptor antagonists such as DM enhance analgesic effects of conventional analgesic agents are likely to take place to a major extent within the spinal cord dorsal horn. Dorsal horn neurons that process pain information have both -opioid and NMDA-receptors. These neurons are at the origin of ascending pathways subserving normal pain and pathophysiological pain. Impulses in primary nociceptive afferents evoke brief high-intensity excitation in dorsal horn nociceptive neurons that is followed by a lower-intensity prolonged impulse discharge. 1 Continuous input over C polymodal nociceptive afferents, but not other types of nociceptive afferents, additionally evokes temporal summation by activation of NMDA-receptors. 2,3 These mechanisms are thought to provide part of the basis for centrally mediated hyperalgesia that occurs in persistent pain states, such as inflammatory pain that follows tissue injury. This hyperalgesia is a normal consequence of injury and subsides with healing of the injured tissue. Generally similar central mechanisms of hyperalgesia also occur with nerve injury. 4,5 Temporal summation of C afferent evoked responses of dorsal horn nociceptive neurons is likely to be mediated by the release of glutamate/aspartate and their activation of NMDA-receptors, leading to prolonged depolarizations. 3,6 NMDAreceptor antagonists have been shown to powerfully block prolonged depolarizations evoked in dorsal horn neurons in in vitro preparations 3,6 and to block the temporal summation evoked by electrical stimulation of C afferents in in vivo preparations without reducing the responses of these same neurons to A-fiber stimulation. 1 3,6 Temporal summation of C afferent evoked responses in dorsal horn neurons reflects some of the mechanisms underlying centrally mediated hyperalgesia that occurs after nerve injury or after inflammation. 1 6 This happens because both phenomena involve the same NMDAreceptor mechanism and at least some of the same intracellular consequences of NMDAreceptor activation. 1 6 Thus, temporal summation has long been considered a central neural mechanism in pathophysiological pain. 1,6 That temporal summation of C fiber mediated responses of dorsal horn nociceptive neurons directly participates in normal pain is shown in human psychophysical experiments on second pain. If the stimulus that activates the C nociceptive afferents occurs at a frequency greater than once every 3 seconds, both second pain and C afferent evoked impulse discharges of dorsal horn nociceptive neurons progressively increase in magnitude. 1,6,7 If the same NMDA-receptor mechanism underlies both electrophysiological and psychophysical expressions of slow temporal summation, then both phenomena should be antagonized by NMDAreceptor antagonists. In a direct test of this hypothesis, oral doses of DM and a vehicle control were given on a double-blind basis to healthy human subjects who rated intensities of first and second pain in response to repeated brief stimuli. 7 DM 30 mg and 45 mg, but not 15 mg, were effective in attenuating temporal summation of second pain, a psychophysical correlate of temporal summation of C afferent mediated responses of dorsal horn nociceptive neurons that has been termed windup. These results further confirm temporal summation of second pain as a psychophysical correlate of windup by providing evidence that DM selectively reduces temporal summation of second pain, as has been shown for windup. Windup is now considered related to the central mechanisms of hyperalgesia. 1,4,6 Similar to what occurs following tissue injury, tonic input from nociceptive C afferents is thought to lead to central sensitization of dorsal horn neurons by means of this windup mechanism. 1,4,6 Moreover, slow temporal summation, electrophysiological and behavioral indices of hyperalgesia can be blocked by NMDA-receptor antagonists, and windup itself can be enhanced by tissue injury evoked hyperalgesia. 2,3 To a certain extent, windup has come to serve as a predictive model for pharmacological and other manipulations that may be used to modulate central mechanisms of hyperalgesia. 1 4 NMDA-Receptor Mechanisms of Hyperalgesia and Narcotic Tolerance/Dependence Within the last few years, several studies have directly or indirectly indicated that narcotic tolerance and narcotic-induced hyperalgesia
3 Vol. 19 No. 1(Suppl.) January 2000 NMDA-Receptor Antagonists and Analgesic Agents S9 involve some of the same NMDA mechanisms that occur during inflammatory and neuropathic pains. 6,8 Of relevant interest is the critically important role that NMDA-receptor activation plays in tolerance to the analgesic effects of narcotics, dependence on narcotics, and narcotic-induced thermal hyperalgesia (see Mao et al. 6 for review). The prevention of analgesic tolerance and hyperalgesia by NMDA antagonists suggests a role for excitatory amino acids in these phenomena. The site of the NMDA-receptor action is likely within the spinal cord dorsal horn. 1,6 Taken together, data on neurogenic and inflammatory thermal hyperalgesia as well as on morphine tolerance/ dependence suggest that central activation of NMDA-receptors is strategically involved in both thermal hyperalgesia with a variety of pathological etiologies and the development of narcotic tolerance and dependence. Once it has developed, thermal hyperalgesia associated with narcotic tolerance can also be potently reversed by intrathecal treatment with MK-801 (another NMDA-receptor antagonist), indicating that NMDA-receptors are critical for the expression of thermal hyperalgesia in morphine-tolerant rats as well. 8 Thermal hyperalgesia develops in association with the development of morphine tolerance and dependence, and NMDA-receptor antagonists potently prevent the appearance of both morphine tolerance and thermal hyperalgesia. Therefore, it is very likely that the origination of morphine tolerance/dependence and the associated thermal hyperalgesia may involve a common NMDA and non-nmda-receptor mechanism. Protein kinase C (PKC) also is involved in the development of morphine tolerance and dependence in rats. Spinal cord levels of membrane-bound PKC (the translocated form of PKC) increase significantly, specifically within the superficial laminae of the dorsal horn (laminae I II), following the development of morphine tolerance and dependence. Furthermore, GM 1 ganglioside potently attenuates both the increase in membrane-bound PKC and the development of tolerance to the analgesic effect of morphine. 9 In addition, GM 1 ganglioside effectively prevents the development of thermal hyperalgesia associated with the development of morphine tolerance and dependence. 9 Similarly, behavioral studies have indicated that nitric oxide (NO) is involved in thermal hyperalgesia induced by peripheral nerve injury or intrathecal NMDA administration and in the development of morphine tolerance and dependence (see Mao et al. 6 for review). The combination of these observations indicates that intracellular PKC and NO may mediate neurogenic and inflammatory thermal hyperalgesia along with the development of narcotic tolerance and dependence, both of which are known to be associated with NMDA-receptor activation. Thus, these converging lines of evidence strongly suggest that NMDA-receptor-mediated intracellular PKC and NO changes may well be associated with thermal hyperalgesia that occurs following the development of narcotic tolerance and dependence as well as with hyperalgesia that follows nerve injury. Several lines of research from different laboratories have demonstrated that postsynaptic opioid -receptor occupation by an exogenous ligand such as morphine may initiate the activation of PKC. 6 Activation of PKC by opioids then increases the sensitivity of the NMDAreceptor by the same mechanisms that occur during persistent pain states. At the same time, activated PKC may uncouple the G-protein associated with the opioid -receptor or modulate the -activated potassium channel. In either case, the net result is reduced responsiveness of the -receptor to an exogenous opioid and, hence, tolerance. The two major components of this mechanism are a positive feedback loop wherein the NMDA receptor becomes progressively sensitized as a result of repeated opioid administration and a negative feedback loop wherein activation of PKC reduces the sensitivity of the receptor. The model makes the following predictions: (1) hyperalgesia should be associated with opioid tolerance, and this hyperalgesia should be blocked by an NMDA antagonist; (2) opioid tolerance should be blocked by an NMDA antagonist to some extent; (3) a preexisting hyperalgesic state, such as that brought about by chronic constrictive nerve injury, should be associated with increased resistance to the analgesic effects of morphine (i.e., tolerance). Results from our laboratory and others support these predictions and offer several clinical implications. 6 There is experimental support for the longheld impressions that patients with neuro-
4 S10 Price et al. Vol. 19 No. 1(Suppl.) January 2000 Fig. 1. Oral administration of MS 32 mg/kg with DM 8 to 64 mg/kg twice daily for 8 days. Animals receiving MS alone showed development of tolerance (rapid decline in maximal analgesic effect after day 3), while animals receiving MS:DM in ratios of 2:1, 1:1, and 1:2 remained responsive. In particular, MS:DM 1:1 appeared to be the optimal ratio for prevention of tolerance. Reproduced from Mao et al. (10) with permission. pathic pain are resistant to opioid analgesics and that hyperalgesia and tolerance develop in some patients who have taken narcotic analgesics for extended periods of time. These problems may be prevented by the co-administration of nontoxic NMDA-receptor antagonists with opioids. Combining NMDA-receptor antagonists with opioid and even nonopioid analgesics may be a way of increasing their analgesic potency in addition to preventing tolerance and dependence. Preclinical animal studies demonstrate the practicality of the combined administration of nontoxic NMDA-receptor antagonists with various types of analgesic drugs. Use of DM to Enhance Morphine Sulfate (MS) Analgesia and Prevent MS Tolerance In a study specifically designed to evaluate the practical feasibility of the combined oral administration of morphine sulfate (MS) with the NMDA-receptor antagonist DM, several key points were demonstrated. DM prevented the development of tolerance to the antinociceptive effects of MS (15, 24, or 32 mg/kg), 10 as shown in Figure 1, and attenuated signs of naloxone-precipitated physical dependence on morphine in rats. A broad range of ratios of MS to DM (2:1, 1:1, and 1:2) was effective. An important feature of this DM-mediated prevention of the development of morphine tolerance is that selective ratios of MS:DM rather than absolute DM seemed effective. The results indicate a wide therapeutic window for potential clinical utility of this MS:DM combination treatment regimen. Finally, DM increased the antinociceptive effects of MS even with a single administration of an MS:DM (1:1) combination (Figure 2). This result has particular relevance to the clinical possibility of combining MS with DM to enhance peak analgesic potency as well as to extend the duration of MS analgesia without enhancing side effects of MS. Thus, it is important that Grass et al. 11 replicated and extended the earlier results of Mao et al. 10 by demonstrating that intraperitoneal injections of DM (30 mg/kg) greatly enhanced peak analgesia and duration of analgesia produced by subcutaneous injections of 5 mg/kg MS. The combination of results from Mao et al. 10 and Grass et al. 11 indicates that oral treatment that combines DM with opiate analgesics may be a powerful approach for simultaneously preventing opiate tolerance and dependence while enhancing both peak and duration of opioid analgesia in humans. A critical feature of the study by Mao et al. 10 was the demonstration that DM increased the antinociceptive effects of low doses of MS. This result is similar to that obtained using a 48- hour delivery of MS and DM through a subcutaneous osmotic pump. 12 Although the highest DM dose (64 mg/kg) alone used in the experi-
5 Vol. 19 No. 1(Suppl.) January 2000 NMDA-Receptor Antagonists and Analgesic Agents S11 Fig. 2. Potentation of MS analgesia by DM following a single dose of the combination. Maximal analgesia with the combination was significantly greater than MS alone during the first 90 minutes after administration (P 0.05). Reproduced from Mao et al. (10) with permission. ments produced some antinociception, no changes in baseline tail-flick latencies were observed in rats receiving lower doses (30 or 15 mg/kg) of DM alone. These results indicate that greater antinociception resulting from a MS:DM combination is not simply an additive effect of MS and DM. Clinically, this would mean that DM might not only be able to prevent morphine tolerance when co-administered with MS but also could enhance morphine analgesia, thereby possibly reducing the dose of opiate analgesics required for pain relief. DM potently facilitates morphine analgesia, at least in part by preventing tolerance. The mechanisms by which morphine analgesia is enhanced and tolerance is prevented are likely to be the same. There is also evidence that DM can reverse morphine tolerance once it is established. 13 Finally, oral DM also facilitates analgesia produced by other opioid analgesics (Mao, Price, Caruso, and Mayer, unpublished observations), suggesting the possibility of other combination analgesic products. References 1. Price DD, Mao J, Mayer DJ. Central neural mechanisms of normal and abnormal pain states. In: Fields HL, Liebeskind JC, eds. Progress in pain research and management. Vol 1. Seattle: IASP Press, 1994: Dickenson AH, Sullivan AF. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurons in the rat. Brain Res 1990;506: Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of postinjury pain hypersensitivity states. Pain 1991;44: Dubner R. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In: Bond M, Charlton E, Woolf, CJ, eds. Proceedings of V World Congress on Pain. Pain Research and Clinical Management. Vol 5. Amsterdam: Elsevier, 1991: Ren K, Hylden JL, Williams GM, Ruda MA, Dubner R. The effects of a noncompetitive NMDA-receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992;50: Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62: Price DD, Mao J, Frenk H, Mayer DJ. The N-methyld-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994;59: Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994;14: Mayer DJ, Mao J, Price DD. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 1995;61: Mao J, Price DD, Caruso F, Mayer DJ. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 1996;67: Grass S, Hoffman O, Xu X-J, Wiesenfeld-Hallin Z. N-methyl-d-aspartate receptor antagonists potentiate morphine s anti-nociceptive effect in the rat. Acta Physiol Scand 1996;158: Manning B, Mao J, Frenk H, Price DD, Mayer DJ. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996;67: Elliott K, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 1994;59:
Pharmacology of Pain Transmission and Modulation
Pharmacology of Pain Transmission and Modulation 2 Jürg Schliessbach and Konrad Maurer Nociceptive Nerve Fibers Pain is transmitted to the central nervous system via thinly myelinated Aδ and unmyelinated
More informationMorphiDex (MS:DM) Double-Blind, Multiple-Dose Studies In Chronic Pain Patients
Vol. 19 No. 1(Suppl.) January 2000 Journal of Pain and Symptom Management S37 Proceedings Supplement NMDA-Receptor Antagonists: Evolving Role in Analgesia MorphiDex (MS:DM) Double-Blind, Multiple-Dose
More informationAbuse Potential of Morphine/ Dextromethorphan Combinations
S26 Journal of Pain and Symptom Management Vol. 19 No. 1(Suppl.) January 2000 Proceedings Supplement NMDA-Receptor Antagonists: Evolving Role in Analgesia Abuse Potential of Morphine/ Dextromethorphan
More informationd-methadone Is Antinociceptive in the Rat Formalin Test 1
0022-3565/97/2832-0648$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 283, No. 2 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationSpinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018
Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive
More informationUpdate on the Neurophysiology of Pain Transmission and Modulation: Focus on the NMDA-Receptor
S2 Journal of Pain and Symptom Management Vol. 19 No. 1(Suppl.) January 2000 Proceedings Supplement NMDA-Receptor Antagonists: Evolving Role in Analgesia Update on the Neurophysiology of Pain Transmission
More informationAnesthesiology, V 92, No 3, Mar 2000
786 Anesthesiology 2000; 92:786 94 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Complete Prevention but Stimulus-dependent Reversion of Morphine Tolerance by the
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress REDUCING THE PAIN FACTOR AN UPDATE ON PERI-OPERATIVE ANALGESIA Sandra Forysth, BVSc DipACVA Institute of Veterinary,
More informationWhat it Takes to be a Pain
What it Takes to be a Pain Pain Pathways and the Neurophysiology of pain Dennis S. Pacl, MD, FACP, FAChPM Austin Palliative Care/ Hospice Austin A Definition of Pain complex constellation of unpleasant
More informationReceptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012
Receptors and Neurotransmitters: It Sounds Greek to Me Cathy Carlson, PhD, RN Northern Illinois University Agenda We will be going through this lecture on basic pain physiology using analogies, mnemonics,
More informationVirtually everyone has experienced pain in one
Transfer of Advances in Sciences into Dental Education Recent Insights into Brainstem Mechanisms Underlying Craniofacial Pain Barry J. Sessle, B.D.S., M.D.S., B.Sc., Ph.D., F.R.S.C., D.Sc. (honorary) Abstract:
More information211MDS Pain theories
211MDS Pain theories Definition In 1986, the International Association for the Study of Pain (IASP) defined pain as a sensory and emotional experience associated with real or potential injuries, or described
More informationSomatosensory Physiology (Pain And Temperature) Richard M. Costanzo, Ph.D.
Somatosensory Physiology (Pain And Temperature) Richard M. Costanzo, Ph.D. OBJECTIVES After studying the material of this lecture the student should be familiar with: 1. The relationship between nociception
More informationPathophysiological Classification of Pain
PATHOPHYSIOLOGY Overview Pathophysiological Classification of Pain Central sensitization/ dysfunctional pain Nociceptive pain - Somatic - Visceral Multiple pain mechanisms may coexist (mixed pain) Neuropathic
More informationPain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH
Pain Pathways Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Objective To give you a simplistic and basic concepts of pain pathways to help understand the complex issue of pain Pain
More informationBy the end of this lecture the students will be able to:
UNIT VII: PAIN Objectives: By the end of this lecture the students will be able to: Review the concept of somatosensory pathway. Describe the function of Nociceptors in response to pain information. Describe
More informationSpecial Issue on Pain and Itch
Special Issue on Pain and Itch Title: Recent Progress in Understanding the Mechanisms of Pain and Itch Guest Editor of the Special Issue: Ru-Rong Ji, PhD Chronic pain is a major health problem world-wide.
More informationPain teaching. Muhammad Laklouk
Pain teaching Muhammad Laklouk Definition Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. Sensory (discriminatiory)
More information3) Most of the organelles in a neuron are located in the A) dendritic region. B) axon hillock. C) axon. D) cell body. E) axon terminals.
Chapter 48 Neurons, Synapses, and Signaling Multiple-Choice Questions 1) A simple nervous system A) must include chemical senses, mechanoreception, and vision. B) includes a minimum of 12 ganglia. C) has
More informationPathophysiology of Pain
Pathophysiology of Pain Wound Inflammatory response Chemical mediators Activity in Pain Path PAIN http://neuroscience.uth.tmc.edu/s2/chapter08.html Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University
More informationSYLLABUS SPRING 2011 COURSE: NSC NEUROBIOLOGY OF PAIN
SYLLABUS NSC 4358 NEUROBIOLOGY OF PAIN SPRING 2011 1 SYLLABUS SPRING 2011 COURSE: NSC 4358 001 NEUROBIOLOGY OF PAIN Instructor: Aage R. Møller PhD E-mail: AMOLLER@UTDALLAS.EDU Class schedule: Main Campus:
More informationSomatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007)
Somatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007) Introduction Adrian s work on sensory coding Spinal cord and dorsal root ganglia Four somatic sense modalities Touch Mechanoreceptors
More informationSan Francisco Chronicle, June 2001
PAIN San Francisco Chronicle, June 2001 CONGENITAL INSENSITIVITY TO PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional)
More informationApplied Neuroscience. Conclusion of Science Honors Program Spring 2017
Applied Neuroscience Conclusion of Science Honors Program Spring 2017 Review Circle whichever is greater, A or B. If A = B, circle both: I. A. permeability of a neuronal membrane to Na + during the rise
More informationPAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus. MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive
PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive MEASUREMENT OF PAIN: A BIG PROBLEM Worst pain ever
More informationPAIN MANAGEMENT in the CANINE PATIENT
PAIN MANAGEMENT in the CANINE PATIENT Laurie Edge-Hughes, BScPT, MAnimSt (Animal Physio), CAFCI, CCRT Part 1: Laurie Edge-Hughes, BScPT, MAnimSt (Animal Physio), CAFCI, CCRT 1 Pain is the most common reason
More informationPain. Pain. Pain: One definition. Pain: One definition. Pain: One definition. Pain: One definition. Psyc 2906: Sensation--Introduction 9/27/2006
Pain Pain Pain: One Definition Classic Paths A new Theory Pain and Drugs According to the international Association for the Study (Merskey & Bogduk, 1994), Pain is an unpleasant sensory and emotional experience
More informationAnalgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer
Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.pharm, Lecturer Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli are transmitted to
More informationCholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation
Br. J. Pharmacol. (1993), 18, 967-973 191" Macmillan Press Ltd, 1993 Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation 'Louise C. Stanfa & Anthony
More informationOpioid Receptor Trafficking in Pain States
Encyclopedia of Pain Springer-Verlag Berlin Heidelberg 2007 10.1007/978-3-540-29805-2_2962 Robert F. Schmidt and William D. Willis Opioid Receptor Trafficking in Pain States Catherine M. Cahill 3, Anne
More informationSeizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical
Are There Sharing Mechanisms of Epilepsy, Migraine and Neuropathic Pain? Chin-Wei Huang, MD, PhD Department of Neurology, NCKUH Basic mechanisms underlying seizures and epilepsy Seizure: the clinical manifestation
More informationS E C T I O N I M E C H A N I S M S A N D E P I D E M I O L O G Y
SECTION I MECHANISMS AND EPIDEMIOLOGY 1 Nociception: basic principles rie suzuki, shafaq sikandar, and anthony h. dickenson University College London Introduction Pain has been a major concern in the clinic
More informationPre-op Interventions to Mitigate Post-op Acute and Chronic Pain
Pre-op Interventions to Mitigate Post-op Acute and Chronic Pain H A R S H A S H A N T H A N N A. M D, M S C A S S O C I A T E P R O F E S S O R D E P A R T M E N T O F A N E S T H E S I A C H R O N I C
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 12 Nervous Tissue Introduction The purpose of the chapter is to: 1. Understand how the nervous system helps to keep controlled conditions within
More informationTourniquet inflation is often used in orthopedic
Preoperative Oral Dextromethorphan Attenuated Tourniquet- Induced Arterial Blood Pressure and Heart Rate Increases in Knee Cruciate Ligament Reconstruction Patients Under General Anesthesia Soichiro Yamashita,
More informationSensory Assessment of Regional Analgesia in Humans
REVIEW ARTICLE Dennis M. Fisher, M.D., Editor-in-Chief Anesthesiology 2000; 93:1517 30 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Sensory Assessment of Regional
More informationQUIZ YOURSELF COLOSSAL NEURON ACTIVITY
QUIZ YOURSELF What are the factors that produce the resting potential? How is an action potential initiated and what is the subsequent flow of ions during the action potential? 1 COLOSSAL NEURON ACTIVITY
More informationBrian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD
Brian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD 1630 Main Street Suite 215 Chester, MD 410-571-9000 www.4-no-pain.com
More informationNervous system. The main regulation mechanism of organism's functions
Nervous system The main regulation mechanism of organism's functions Questions Neuron The reflex arc The nervous centers Properties of the nervous centers The general principles of coordination Inhibition
More informationThe Nervous System. Nervous System Functions 1. gather sensory input 2. integration- process and interpret sensory input 3. cause motor output
The Nervous System Nervous System Functions 1. gather sensory input 2. integration- process and interpret sensory input 3. cause motor output The Nervous System 2 Parts of the Nervous System 1. central
More informationSEX DIFFERENCES IN OPIOID ANTINOCICEPTION: MODULATION BY THE N- METHYL-D-ASPARTATE SYSTEM. Lisa Madonia Lomas
SEX DIFFERENCES IN OPIOID ANTINOCICEPTION: MODULATION BY THE N- METHYL-D-ASPARTATE SYSTEM Lisa Madonia Lomas A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in
More information10.1: Introduction. Cell types in neural tissue: Neurons Neuroglial cells (also known as neuroglia, glia, and glial cells) Dendrites.
10.1: Introduction Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Cell types in neural tissue: Neurons Neuroglial cells (also known as neuroglia, glia, and glial
More informationLecture 22: A little Neurobiology
BIO 5099: Molecular Biology for Computer Scientists (et al) Lecture 22: A little Neurobiology http://compbio.uchsc.edu/hunter/bio5099 Larry.Hunter@uchsc.edu Nervous system development Part of the ectoderm
More informationNeurochemical mechanisms of stimulation-produced analgesia: Comparison of tests involving tonic and phasic pain
Physiological Psychology 1984, Vol. 12 (4), 280-284 Neurochemical mechanisms of stimulation-produced analgesia: Comparison of tests involving tonic and phasic pain BEVERLY E. THORN and KENNETH E. PLOTKIN
More informationGlycine-gated ion channels Converging mechanism and therapeutic potentials
Glycine-gated ion channels Converging mechanism and therapeutic potentials Li Zhang Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health,
More informationCancer-induced bone pain
Cancer-induced bone pain Common Prevalent in particular cancers: breast (73%), prostate (68%), thyroid (42%), lung (36%), renal (35%), colon (5%) Correlates with an increased morbidity Reduced performance
More informationIntroduction to some interesting research questions: Molecular biology of the primary afferent nociceptor
Introduction to some interesting research questions: Molecular biology of the primary afferent nociceptor NOCICEPTORS ARE NOT IDENTICAL PEPTIDE SubP/CGRP Trk A NON-PEPTIDE IB4 P2X 3 c-ret Snider and McMahon
More informationPAIN. Physiology of pain relating to pain management
PAIN Physiology of pain relating to pain management What is pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. (Melzac and Wall) The generation of pain
More informationAnaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation
Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Dr Ajay Kumar Senior Lecturer Macquarie and Melbourne University Introduction Amputee
More informationChapter 19. Pain Management, Rest, and Restorative Sleep. Fundamentals of Nursing Care Concepts, Connections, & Skills, Second Edition
Chapter 19 Pain Management, Rest, and Restorative Sleep Presented by Farahnaz Danandeh, Nursing Educator @ GHOC Classifications of Pain Acute: Sudden pain; short duration of less than 6 months Chronic:
More informationChapter 45: Synapses Transmission of Nerve Impulses Between Neurons. Chad Smurthwaite & Jordan Shellmire
Chapter 45: Synapses Transmission of Nerve Impulses Between Neurons Chad Smurthwaite & Jordan Shellmire The Chemical Synapse The most common type of synapse used for signal transmission in the central
More informationRECENT ADVANCES IN THE PATHOPHYSIOLOGY OF ACUTE PAIN
Br. J. Anaesth. (1989), 63, 139-146 RECENT ADVANCES IN THE PATHOPHYSIOLOGY OF ACUTE PAIN C. J. WOOLF The peripheral receptors of the sensory systems have transduction mechanisms that ensure maximal sensitivity
More informationNeurobiology of Fibromyalgia Syndrome
Neurobiology of Fibromyalgia Syndrome DONALD D. PRICE and ROLAND STAUD ABSTRACT. Accumulating evidence suggests that fibromyalgia syndrome (FM) pain is maintained by tonic impulse input from deep tissues,
More informationChapter 7 Nerve Cells and Electrical Signaling
Chapter 7 Nerve Cells and Electrical Signaling 7.1. Overview of the Nervous System (Figure 7.1) 7.2. Cells of the Nervous System o Neurons are excitable cells which can generate action potentials o 90%
More informationAbbott s TRPV1 Antagonist Program
Abbott s TRPV1 Antagonist Program Connie R. Faltynek, Ph.D. Sr. Director, Neuroscience and Pain Discovery American Pain Society Annual Meeting Basic Science Dinner Symposium May 9, 2008 Early History of
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More informationAmeen Alsaras. Ameen Alsaras. Mohd.Khatatbeh
9 Ameen Alsaras Ameen Alsaras Mohd.Khatatbeh Nerve Cells (Neurons) *Remember: The neural cell consists of: 1-Cell body 2-Dendrites 3-Axon which ends as axon terminals. The conduction of impulse through
More informationChapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline
Chapter 11 Introduction to the Nervous System and Nervous Tissue Chapter Outline Module 11.1 Overview of the Nervous System (Figures 11.1-11.3) A. The nervous system controls our perception and experience
More informationCorporate Medical Policy
Corporate Medical Policy Intravenous Anesthetics for the Treatment of Chronic Pain File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intravenous_anesthetics_for_the_treatment_of_chronic_pain
More informationHow Synapses Integrate Information and Change
How Synapses Integrate Information and Change Rachel Stewart class of 2016 http://neuroscience.uth.tmc.edu/s1/chapter06.html http://neuroscience.uth.tmc.edu/s1/chapter07.html Chris Cohan, Ph.D. Dept. of
More informationPain Mechanisms. Prof Michael G Irwin MD, FRCA, FANZCA FHKAM Head Department of Anaesthesiology University of Hong Kong. The Somatosensory System
ain Mechanisms rof Michael G Irwin MD, FRCA, FANZCA FHKAM Head Department of Anaesthesiology University of Hong Kong The Somatosensory System Frontal cortex Descending pathway eriaqueductal gray matter
More informationINTERACTIVE QUESTIONS
INTERACTIVE QUESTIONS Pathophysiology What is pain? Pathophysiology Does everyone feel pain the same way? Pathophysiology From a practical point of view, how do you classify pain? Pathophysiology What
More informationPain and endometriosis: How to optimize the medical management?
Pre-congress course Endometriosis sand pelvic pain 1st Society for endometriosis and uterine Disorders Meeting Paris, 7-9 May 2015 Pain and endometriosis: How to optimize the medical management? J. FAIDHERBE
More informationAnalgesics, pain and tolerance: The St John s discussion
EDITORIAL Analgesics, pain and tolerance: The St John s discussion Four of the articles in the present issue of Pain Research & Management discuss preclinical issues relevant to understanding the changes
More informationFrom preemptive to preventive analgesia Esther M. Pogatzki-Zahn and Peter K. Zahn
From preemptive to preventive analgesia Esther M. Pogatzki-Zahn and Peter K. Zahn Purpose of review Much effort has been taken to prove that a treatment initiated before surgery is more effective in reducing
More informationMultimodal analgesic therapy has gained widespread
TOPICAL REVIEW Analgesia for Anesthetized Patients Kip A. Lemke, DVM, MSc, Dipl. ACVA, and Catherine M. Creighton, DVM Many perioperative pain management protocols for cats and dogs are overly complex,
More informationMemory Systems II How Stored: Engram and LTP. Reading: BCP Chapter 25
Memory Systems II How Stored: Engram and LTP Reading: BCP Chapter 25 Memory Systems Learning is the acquisition of new knowledge or skills. Memory is the retention of learned information. Many different
More informationElectrophysiology. General Neurophysiology. Action Potentials
5 Electrophysiology Cochlear implants should aim to reproduce the coding of sound in the auditory system as closely as possible, for best sound perception. The cochlear implant is in part the result of
More informationSynaptic plasticityhippocampus. Neur 8790 Topics in Neuroscience: Neuroplasticity. Outline. Synaptic plasticity hypothesis
Synaptic plasticityhippocampus Neur 8790 Topics in Neuroscience: Neuroplasticity Outline Synaptic plasticity hypothesis Long term potentiation in the hippocampus How it s measured What it looks like Mechanisms
More informationThe Role of Ketamine in the Management of Complex Acute Pain
The Role of Ketamine in the Management of Complex Acute Pain Dr James Bennett Consultant Anaesthetist Consultant Lead for Inpatient Pain Service East Sussex Healthcare NHS Trust STAPG Committee Member
More informationTHE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates
OPIOID PHARMACOLOGY PCTH 300/305 Andrew Horne, PhD andrew.horne@ubc.ca MEDC 309 THE OPIUM POPPY Papaver somniferum Sleep-bringing poppy Poppy Seeds Opiates Opium Poppy Straw 1 OPIATES VS. OPIOIDS Opiates:
More informationAcute Pain Management in the Opioid Tolerant Patient. Objectives. Opioids. The participant will be able to define opioid tolerance
Acute Pain Management in the Opioid Tolerant Patient Kathleen M. Colfer, MSN, RN-BC Clinical Nurse Specialist Acute Pain Management Service Department of Anesthesiology Thomas Jefferson University Hospital
More informationBasic Neuroscience. Sally Curtis
The Physiology of Pain Basic Neuroscience Sally Curtis sac3@soton.ac.uk The behaviour of humans is a result of the actions of nerves. Nerves form the basis of Thoughts, sensations and actions both reflex
More informationSynaptic transmission
Outline Synaptic transmission Sompol Tapechum M.D., Ph.D. Department of Physiology Faculty of Medicine Siriraj Hospital, Bangkok, Thailand. sisth@mahidol.ac.th 2 Structure of synapse Modes of synaptic
More information5-Nervous system II: Physiology of Neurons
5-Nervous system II: Physiology of Neurons AXON ION GRADIENTS ACTION POTENTIAL (axon conduction) GRADED POTENTIAL (cell-cell communication at synapse) SYNAPSE STRUCTURE & FUNCTION NEURAL INTEGRATION CNS
More informationBIPN 140 Problem Set 6
BIPN 140 Problem Set 6 1) The hippocampus is a cortical structure in the medial portion of the temporal lobe (medial temporal lobe in primates. a) What is the main function of the hippocampus? The hippocampus
More informationThursday, January 22, Nerve impulse
Nerve impulse Transmembrane Potential caused by ions moving through cell membrane at different rates Two main ions of concern Na + - Sodium K + - potassium Cell membrane not freely permeable therefore
More informationRESEARCH AND CLINICAL REVIEW. Nociception: New Understandings and Their Possible Relation to Somatic Dysfunction and Its Treatment
OHIO Volume 15 SPRING 2005 RESEARCH AND CLINICAL REVIEW A joint publication of the Ohio University College of Osteopathic Medicine and the Ohio Osteopathic Foundation Pain Projection Pathway Dorsal root
More informationProceeding of the SEVC Southern European Veterinary Conference
www.ivis.org Proceeding of the SEVC Southern European Veterinary Conference Oct. 17-19, 2008 Barcelona, Spain http://www.sevc.info Reprinted in the IVIS website with the permission of the SEVC www.ivis.org
More informationSENSORY FUNCTIONS OF THE SKIN OF HUMANS
SENSORY FUNCTIONS OF THE SKIN OF HUMANS SENSORY FUNCTIONS OF THE SKIN OF HUMANS EDITED BY DAN R. KENSHALO Florida State University Tallahassee, Florida PLENUM PRESS NEW YORK AND LONDON Library of Congress
More informationWhat do we want for pain medications?
New Trends in Pain Pharmacotherapy Dr. Chi Wai Cheung MBBS(HK), FHKCA, FHKAM(Anaesthesiology), Dip Pain Mgt(HKCA) Clinical Assistant Professor Department of Anaesthesiology The University of Hong Kong
More informationMorphine analgesic tolerance in 129P3/J and 129S6/SvEv mice
Pharmacology, Biochemistry and Behavior 85 (2006) 769 779 www.elsevier.com/locate/pharmbiochembeh Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice Camron D. Bryant a,b,c,, Kristofer W. Roberts
More informationLisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR
Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR 1 1. Skin disorders, including cysts, acne, and dermatitis. 2. Joint disorders, including osteoarthritis. 3. Back problems. Source: Mayo
More informationBIPN 140 Problem Set 6
BIPN 140 Problem Set 6 1) Hippocampus is a cortical structure in the medial portion of the temporal lobe (medial temporal lobe in primates. a) What is the main function of the hippocampus? The hippocampus
More informationPathophysiology of Pain. Ramon Go MD Assistant Professor Anesthesiology and Pain medicine NYP-CUMC
Pathophysiology of Pain Ramon Go MD Assistant Professor Anesthesiology and Pain medicine NYP-CUMC Learning Objectives Anatomic pathway of nociception Discuss the multiple target sites of pharmacological
More informationBlockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
British Journal of Pharmacology (2000) 131, 875 ± 884 ã 2000 Macmillan Publishers Ltd All rights reserved 0007 ± 1188/00 $15.00 www.nature.com/bjp Blockade and reversal of spinal morphine tolerance by
More informationRefractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation
Refractory Central Neurogenic Pain in Spinal Cord Injury Case Presentation Edwin B. George, MD, PhD Wayne State University John D. Dingell VAMC 2012 Disclosures This continuing education activity is managed
More informationEvaluation of Gabapentin and S-( )-3-Isobutylgaba in a Rat Model of Postoperative Pain
0022-3565/97/2823-1242$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 282, No. 3 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationSensory coding and somatosensory system
Sensory coding and somatosensory system Sensation and perception Perception is the internal construction of sensation. Perception depends on the individual experience. Three common steps in all senses
More informationChapter 11: Nervous System and Nervous Tissue
Chapter 11: Nervous System and Nervous Tissue I. Functions and divisions of the nervous system A. Sensory input: monitor changes in internal and external environment B. Integrations: make decisions about
More informationHole s Human Anatomy and Physiology Eleventh Edition. Chapter 10
PowerPoint Lecture Outlines to accompany Hole s Human Anatomy and Physiology Eleventh Edition Shier Butler Lewis Chapter 10 Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction
More informationEffect of Intravenous Lidocaine on the Neuropathic Pain of Failed Back Surgery Syndrome
Original Article Korean J Pain 2012 April; Vol. 25, No. 2: 94-98 pissn 2005-9159 eissn 2093-0569 http://dx.doi.org/10.3344/kjp.2012.25.2.94 Effect of Intravenous Lidocaine on the Neuropathic Pain of Failed
More informationPotential for delta opioid receptor agonists as analgesics in chronic pain therapy
Potential for delta opioid receptor agonists as analgesics in chronic pain therapy David Kendall & Bengt von Mentzer; PharmNovo AB/UK Alex Conibear & Eamonn Kelly, University of Bristol Junaid Asghar,
More informationA study on analgesic effect of Caryophyllus aromaticus by formalin test in albino rats
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 2 Issue 1 January 2013 PP.28-35 A study on analgesic effect of Caryophyllus aromaticus
More informationPeriod: Date: Module 28: Nervous System, Student Learning Guide
Name: Period: Date: Module 28: Nervous System, Student Learning Guide Instructions: Work in pairs (share a computer). Make sure that you log in for the first quiz so that you get credit. Go to www.sciencemusicvideos.com.
More informationAnti-nerve growth factor antibody attenuates chronic morphine treatmentinduced tolerance in the rat
Cheppudira et al. BMC Anesthesiology (2016) 16:73 DOI 10.1186/s12871-016-0242-x RESEARCH ARTICLE Open Access Anti-nerve growth factor antibody attenuates chronic morphine treatmentinduced tolerance in
More informationPortions from Chapter 6 CHAPTER 7. The Nervous System: Neurons and Synapses. Chapter 7 Outline. and Supporting Cells
CHAPTER 7 The Nervous System: Neurons and Synapses Chapter 7 Outline Neurons and Supporting Cells Activity in Axons The Synapse Acetylcholine as a Neurotransmitter Monoamines as Neurotransmitters Other
More informationChronic pain: We should not underestimate the contribution of neural plasticity. *Gwyn N Lewis 1, David A Rice 1,2
Chronic pain: We should not underestimate the contribution of neural plasticity *Gwyn N Lewis 1, David A Rice 1,2 1 Health and Rehabilitation Research Institute, AUT University, Auckland, New Zealand 2
More information